D. E. Shaw & Co., Inc. Vista Gen Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $228,560 - $449,329	-259,728 Reduced 95.14%	13,274 $12,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $295,945 - $542,566	259,601 Added 1937.18%	273,002 $339,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $149,626 - $247,287	-89,597 Reduced 86.99%	13,401 $26,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $109,400 - $144,058	-41,756 Reduced 28.85%	102,998 $282,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $283,717 - $455,975	144,754 New	144,754 $456,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.